ITGA5 is associated with prognosis marker and immunosuppression in head and neck squamous cell carcinoma
ITGA5 can be used as a potential marker to systematically associate with prognosis of HNSCC, which may be associated with HNSCC malignant phenotype, immunosuppression and chemotherapy resistance.
Authors
- Yongkuan Wang
- Xi Chen (ORCID: https://orcid.org/0000-0002-5807-4219)
- Meng Zhang (ORCID: https://orcid.org/0000-0003-4935-4005)
- Xiaofang Chen (ORCID: https://orcid.org/0000-0003-2058-5731)
- Jianmin Liu (ORCID: https://orcid.org/0000-0002-0179-1751)
Institutions
- Fuyang City People's Hospital (CN)
- Deyang Stomatological Hospital (CN)
- Sichuan Cancer Hospital (CN)
Publication Details
- Journal
- Diagnostic Pathology
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1186/s13000-024-01559-1
- Citations
- 4
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.13